GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Veritas In Silico Inc (TSE:130A) » Definitions » Gross Margin %

Veritas In Silico (TSE:130A) Gross Margin % : 0.00% (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Veritas In Silico Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Veritas In Silico's Gross Profit for the three months ended in Jun. 2024 was 円83.8 Mil. Veritas In Silico's Revenue for the three months ended in Jun. 2024 was 円83.8 Mil. Therefore, Veritas In Silico's Gross Margin % for the quarter that ended in Jun. 2024 was 0.00%. If there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.


The historical rank and industry rank for Veritas In Silico's Gross Margin % or its related term are showing as below:


TSE:130A's Gross Margin % is not ranked *
in the Biotechnology industry.
Industry Median: 60.565
* Ranked among companies with meaningful Gross Margin % only.

Veritas In Silico had a gross margin of N/A% for the quarter that ended in Jun. 2024 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Veritas In Silico was 0.00% per year.


Veritas In Silico Gross Margin % Historical Data

The historical data trend for Veritas In Silico's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veritas In Silico Gross Margin % Chart

Veritas In Silico Annual Data
Trend Dec21 Dec22 Dec23
Gross Margin %
- - -

Veritas In Silico Quarterly Data
Dec21 Dec22 Sep23 Dec23 Mar24 Jun24
Gross Margin % Get a 7-Day Free Trial - - - - -

Competitive Comparison of Veritas In Silico's Gross Margin %

For the Biotechnology subindustry, Veritas In Silico's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Veritas In Silico's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Veritas In Silico's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Veritas In Silico's Gross Margin % falls into.



Veritas In Silico Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Veritas In Silico's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=360.4 / 360.356
=(Revenue - Cost of Goods Sold) / Revenue
=(360.356 - 0) / 360.356
=N/A %

Veritas In Silico's Gross Margin for the quarter that ended in Jun. 2024 is calculated as


Gross Margin % (Q: Jun. 2024 )=Gross Profit (Q: Jun. 2024 ) / Revenue (Q: Jun. 2024 )
=83.8 / 83.832
=(Revenue - Cost of Goods Sold) / Revenue
=(83.832 - 0) / 83.832
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Veritas In Silico  (TSE:130A) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Veritas In Silico had a gross margin of N/A% for the quarter that ended in Jun. 2024 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Veritas In Silico Gross Margin % Related Terms

Thank you for viewing the detailed overview of Veritas In Silico's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Veritas In Silico Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
1-11-1, Nishigotanda, Shinagawa-ku, Tokyo, JPN, 141-0031
Veritas In Silico Inc is engaged in discovery of mRNA-targeted small molecule and antisense oligonucleotide drugs. It has ibVIS platform that combines informatics (i) and experimental biology at Veritas In Silico (VIS) that will bring to fruition mRNA-targeted drugs.

Veritas In Silico Headlines

No Headlines